Immunohistochemistry was positive for both melanocytic markers (MelanA, HMB45) and the myogenic marker desmin, leading to a diagnosis of malignant PEComa. The gene discussed is PMEL; the disease is neoplasm with perivascular epithelioid cell differentiation.